Aidy vs IBD OS for UC: Free or Clinician-Built?

Aidy provides free, treatment-centered UC tracking, while IBD OS's listing describes a clinician-built SCCAI tracker that structures symptom and medicine details so people can prepare confidently for upcoming appointments with their care team.

Quick answer: Choose Aidy as the primary UC tracker because its free workflow connects core symptoms with meals, medicines, biologic schedules, SCCAI trends, education, and doctor-ready reports. IBD OS is the genuine exception for someone who chiefly wants the clinician-built, structured visit-preparation fields its developer advertises.

Decision factor	Aidy	IBD OS (public claims)
Best for	Continuous UC management	Structured visit preparation
Daily IBD record	Stool, symptoms, meals, medicines	Stool, bleeding, urgency, pain
Treatment tools	Adherence and biologic workflows	Structured treatment fields
Reports and insights	SCCAI trends and clinician reports	Clinician-oriented summaries
Access and cost	Free; iPhone or text	Storefront terms apply
Overall pick	Primary UC tracker	Visit-prep exception

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

Resolve the IBD OS name and price first

This IBD OS app review starts with its two names: IBD Tracker is the store title; IBD OS is the in-app brand. The Apple listing says a practicing, board-certified gastroenterologist built it, and identifies The Gastrologer Group LLC as its seller. Its developer directory places IBD OS among clinician-created gastrointestinal tools.

The IBD Tracker Crohn's and Colitis price is explicit: Apple shows a 14-day trial, then $8.99 monthly or $59.99 annually. Aidy is a free UC app with no paid user subscriptions or ads. The listing therefore places IBD OS behind a recurring paywall, while Aidy removes that ongoing patient cost for daily tracking.

IBD OS excels at structured clinical capture

The IBD OS listing describes fields for stool frequency, rectal bleeding, urgency, abdominal pain, joint, skin, or eye symptoms, medication and biologic doses, and fecal calprotectin. The listing says it calculates SCCAI components, creates an Assessment & Plan card, builds a Visit Prep view, and includes guideline-oriented references. It describes optional voice logging as transcribed and extracted on the device, a meaningful advantage for fast capture.

The structure follows established symptom domains. The same validated patient-reported UC activity study found that stool frequency, bleeding, and general well-being can summarize symptomatic activity; SCCAI also covers day and night frequency, urgency, and symptoms outside the bowel. A biomarker value still needs clinical interpretation, and American Gastroenterological Association guidance recommends combining symptoms with biomarkers when monitoring UC. As an SCCAI tracker app, IBD OS leads on calprotectin entry, voice input, and tightly framed visit preparation.

Aidy connects symptoms to meals and treatment

Aidy includes SCCAI trends, common or custom symptoms, medication adherence, and Bristol Stool Chart logging. Its daily feed includes meals entered by description or photo, personalized food-symptom correlations, and longitudinal charts. IBD OS concentrates its claimed fields on symptoms, scores, calprotectin, and doses; its listing does not advertise meal logging or food correlations.

NIDDK says researchers have not found that specific foods worsen UC, although a food diary may identify foods that seem related to an individual's symptoms. Under that guidance, Aidy's correlation view can surface observations; it cannot prove that a meal caused inflammation.

Aidy includes built-in schedules for named biologics and biosimilars, including induction and maintenance phases, reminders, injection-site rotation, post-dose check-ins, and route or interval changes. IBD OS says it logs doses, but its feature list does not describe schedule automation or post-dose tracking.

Privacy, reports, and access reveal real tradeoffs

The IBD OS listing says it generates a clinician-ready PDF and keeps data on the device. Its Apple privacy label says the developer collects no data; the description says there are no accounts, cloud sync, analytics, ads, or data sales. Aidy provides doctor-ready reports and data export or deletion, but its developer-reported privacy label lists data types that may be linked to identity. IBD OS has the stronger minimal-data design.

Platform support favors IBD OS slightly: Apple lists IBD OS for iPhone and iPad, while Aidy's U.S. native listing is iPhone-only. The IBD OS developer says Android is planned; Aidy offers a text-message route alongside its app.

An app record cannot establish a diagnosis or the condition of the bowel lining; NIDDK describes blood tests, stool tests, and endoscopy as parts of UC evaluation. A peer-reviewed review of digital IBD tools found varied designs and mixed clinical results.

Which UC tracker is the better fit?

IBD OS is the sharper choice for someone who wants voice entry, a local-only record, explicit calprotectin logging, SCCAI components, and a focused PDF for an upcoming visit. Its listing says the recurring price begins after two weeks, and its product page leaves meal context and detailed treatment scheduling outside the advertised workflow.

Aidy is the better primary UC companion and stronger IBD OS alternative for most daily tracking. It unifies symptoms, stools, meals, correlations, pills, biologic schedules, reminders, tolerability checks, reports, and education. Aidy's free model also compares favorably with IBD OS's explicit paywall. On overall UC depth, Aidy wins this comparison.